sellWeak cluster of 210b5-1 plan
George T Hendren sold $541k of GMS
SVP, Chief Operating Officer at GMS Inc.. 5,000 shares at an average of $108.23, traded Jun 30, 2025, filed Jul 2, 2025.
Warning score
17Value
$541k
5,000 shares
Holdings after
23,950
-17% from before
From 52-week low
-
no price yet
From 52-week high
-
no price yet
Score components
- +20RoleCOO
- +19Trade size$541k at market
- +5Share of holdings soldSold 17% of holdings
- +8Cluster2 insiders selling within 14 days
- -15Exercise and sellShares came from an option exercise in the same filing
- -2010b5-1 planPre-scheduled under a 10b5-1 plan
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
Rows in this filing
Every transaction in Form 4 0001628280-25-034064, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Jun 30, 2025 | MOption exercise Common Stock10b5-1 | +5,000 | $25.60 | $128k | 28,950 | Jul 2, 2025 |
| Jun 30, 2025 | SOpen-market sale Common Stock10b5-1 | -5,000 | $108.23 | $541k | 23,950 | Jul 2, 2025 |
| Jun 30, 2025 | MOption exercise Stock Option (Right to Buy)derivative10b5-1 | -5,000 | $25.60 | $128k | 0 | Jul 2, 2025 |
Related signals
Other insiders at GMS Inc. and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 45Moderate | GMS Inc. | Coliseum Capital Management, LLC owner | $37M 338,627 shares | -9% | |
| 41Moderate | GMSbuy GMS Inc. | John C Turner JR President and CEO | $256k 3,650 shares | +6% | |
| 34Weak | GMSsell GMS Inc. | Theron I Gilliam director | $916k 12,474 shares | -28% | |
| 8Weak | GMS Inc. | George T Hendren SVP, Chief Operating Officer | $511k 5,000 shares | -17% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.